AKT1 and neoplasm: Mice were classified into study and control groups (n = 8 per group) for treatment with placebo control or the combination of AKT and mTOR inhibitors for 21 days, which resulted in a significant reduction in tumor growth (p = 0.0068) in the treatment group (Figure 5C).